See also this year's filing and all EDGAR filings for this company.
PDF Report 0001274792_2017_Merrimack_Pharmaceuticals_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001274792, Merrimack Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 57,435,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 7,582,000 |
| 2 | PropertyPlantAndEquipmentNet | 15,765,000 |
| 3 | remainder_Assets | 701,000 |
| 4 | LiabilitiesCurrent | 88,222,000 |
| 5 | LiabilitiesNoncurrent | 216,861,000 |
| 6 | remainder_Liabilities | 29,059,000 |
| 7 | CostOfGoodsAndServicesSold | 41,242,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 169,221,034 |
| 9 | ResearchAndDevelopmentExpense | 160,905,803 |
| 10 | remainder_Expenses | 115,173,409 |
| 11 | remainder_Revenues | 132,006,672 |
| 12 | remainder_NetIncome | 501,032 |
| 13 | remainder_ComprehensiveNetIncome | -90,792 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 81,483,000 |
| 1 | Liabilities | 334,142,000 |
| 2 | Expenses | 486,542,246 |
| 3 | Revenues | 132,006,672 |
| 4 | StockholdersEquity | -252,659,000 |
| 5 | NetIncome | -354,034,542 |
| 6 | ComprehensiveNetIncome | -354,079,938 |
| 7 | BaseVar | 517,382,871 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -4.35 |
| 9 | EconomicCapitalRatio | 0.309 |
Edgar->Model Mapping
Feature Distribution
Change over Time
